Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

19 September 2024 : Clinical Research  

Intravenous Lidocaine Response as a Predictor for Oral Oxcarbazepine Efficacy in Neuropathic Pain Syndrome: A Prospective Cohort Study

Sukunya Jirachaipitak1ABCDEF, Pramote Euasobhon1ABCDEFG*, Suthanee Cenpakdee1ABEF, Suratsawadee Wangnamthip1ABDE, Pranee Rushatamukayanunt1ABDE

DOI: 10.12659/MSM.945612

Med Sci Monit 2024; 30:e945612

Figure 2 Relation of pain reduction after lidocaine infusion and after oxcarbazepine treatment. There are 21 of 32 patients (a small circle represents 1 patient) who demonstrated a good correlation of pain reduction between i.v. lidocaine infusion and oral oxcarbazepine (OXC) treatment in the range of ±20% (area between 2 orange lines). Figure created using Microsoft Word (Version 2019, Microsoft Corporation).

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750